Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 23074319)

1.

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes.

Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A.

Clin Infect Dis. 2013 Jan;56(2):267-70. doi: 10.1093/cid/cis883. Epub 2012 Oct 16.

2.

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.

Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A.

Vaccine. 2013 Dec 17;32(1):119-23. doi: 10.1016/j.vaccine.2013.10.055. Epub 2013 Oct 28.

3.

Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine.

Fan YC, Chen JM, Chiu HC, Chen YY, Lin JW, Shih CC, Chen CM, Chang CC, Chang GJ, Chiou SS.

PLoS Negl Trop Dis. 2012;6(9):e1834. doi: 10.1371/journal.pntd.0001834. Epub 2012 Sep 27.

5.

Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.

Liu X, Yu Y, Li M, Liang G, Wang H, Jia L, Dong G.

Vaccine. 2011 Mar 3;29(11):2127-30. doi: 10.1016/j.vaccine.2010.12.108. Epub 2011 Jan 13.

PMID:
21237278
7.

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.

Beasley DW, Li L, Suderman MT, Guirakhoo F, Trent DW, Monath TP, Shope RE, Barrett AD.

Vaccine. 2004 Sep 9;22(27-28):3722-6.

PMID:
15315852
8.

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines.

Erra EO, Askling HH, Rombo L, Riutta J, Vene S, Yoksan S, Lindquist L, Pakkanen SH, Huhtamo E, Vapalahti O, Kantele A.

Clin Infect Dis. 2012 Sep;55(6):825-34. doi: 10.1093/cid/cis542. Epub 2012 Jun 13.

9.

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.

Bonaparte M, Dweik B, Feroldi E, Meric C, Bouckenooghe A, Hildreth S, Hu B, Yoksan S, Boaz M.

BMC Infect Dis. 2014 Mar 21;14:156. doi: 10.1186/1471-2334-14-156.

11.

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Monath TP, Guirakhoo F, Nichols R, Yoksan S, Schrader R, Murphy C, Blum P, Woodward S, McCarthy K, Mathis D, Johnson C, Bedford P.

J Infect Dis. 2003 Oct 15;188(8):1213-30. Epub 2003 Oct 3.

12.

T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.

Aihara H, Takasaki T, Toyosaki-Maeda T, Suzuki R, Okuno Y, Kurane I.

Viral Immunol. 2000;13(2):179-86.

PMID:
10892998
13.

Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine.

Fan YC, Chen JM, Chen YY, Lin JW, Chiou SS.

Vet Microbiol. 2013 May 3;163(3-4):248-56. doi: 10.1016/j.vetmic.2013.01.017. Epub 2013 Jan 29.

PMID:
23415032
14.

Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows.

Imoto J, Ishikawa T, Yamanaka A, Konishi M, Murakami K, Shibahara T, Kubo M, Lim CK, Hamano M, Takasaki T, Kurane I, Udagawa H, Mukuta Y, Konishi E.

Vaccine. 2010 Oct 28;28(46):7373-80. doi: 10.1016/j.vaccine.2010.09.008. Epub 2010 Sep 17.

PMID:
20851083
16.

Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Mar 12;59(RR-1):1-27.

17.

Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers.

Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S.

Vaccine. 2011 Aug 11;29(35):5925-31. doi: 10.1016/j.vaccine.2011.06.062. Epub 2011 Jun 30.

PMID:
21723353
18.

Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice.

Dewasthaly SS, Bhonde GS, Shankarraman V, Biswas SM, Ayachit VM, Gore MM.

Protein Pept Lett. 2007;14(6):543-51.

PMID:
17627594
19.

Development of a recombinant vaccine against Japanese encephalitis.

Kaur R, Vrati S.

J Neurovirol. 2003 Aug;9(4):421-31. Review.

PMID:
12907387
20.

Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).

Kikukawa A, Gomi Y, Akechi M, Onishi T, Manabe S, Namazue J, Fuke I, Ishikawa T, Okuno Y, Ueda S.

Vaccine. 2012 Mar 16;30(13):2329-35. doi: 10.1016/j.vaccine.2012.01.054. Epub 2012 Jan 31.

PMID:
22306856
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk